NCT02549911.
Trial name or title | Hyperthermic intraperitoneal chemotherapy, intravenous chemotherapy combined with surgery for the treatment of advanced gastric cancer with peritoneal metastasis |
Methods | Phase 2 Intervention Model: Single‐group assignment Masking: Open‐label Primary Purpose: Treatment |
Participants | N = 40 18‐75 years Gastric cancer confirmed by endoscopic biopsy , and enhanced CT suspected to have peritoneal metastasis, including ascites, ovarian metastasis, omentum or peritoneal metastasis. |
Interventions | Experimental: HIPEC,Chemotherapy AND surgery
Intervention: Other: HIPEC, chemotherapy AND surgery |
Outcomes | R0 resection [Time frame: 3 months] Adverse events [Time frame: 6 months] Overall survival time [Time Frame: 3 years] |
Starting date | September 2015 |
Contact information | Yian Du, MD; ypfzmu@163.com; 86‐571‐88128031 |
Notes |